A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
Drugs that control the addition of m6A to mRNA could take advantage of this process. By specifically suppressing m6A, it would be possible to produce more proteins with desirable functions—and ...
From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.
News Medical on MSN2d
Disrupting the RBM42 protein could throw a wrench in the gears of cancer's growthFor decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...
TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...
TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback